Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens

M. J. Bubar, L. R. McMahon, P. De Deurwaerdère, U. Spampinato, Kathryn Cunningham

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The role for serotonin (5-HT) in mediating the behavioral effects of cocaine may be related in part to the ability of 5-HT to modulate the function of the dopamine (DA) mesoaccumbens pathways. In the present study, the ability of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine (10 mg/kg, IP) and fluvoxamine (10 and 20 mg/kg, IP) to alter cocaine (10 mg/kg, IP)-induced hyperactivity and DA release in the nucleus accumbens (NAc) was analyzed in male Sprague-Dawley rats. Systemic administration of either fluoxetine or fluvoxamine enhanced cocaine-induced locomotor activity in a dose-dependent manner; fluoxetine (10 mg/kg, IP) also enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. To test the hypothesis that the NAc serves as the locus of action underlying these effects following systemic cocaine administration, fluoxetine (1 and 3 μg/0.2 μl/side) or fluvoxamine (1 and 3 μg/0.2 μl/side) was microinfused into the NAc shell prior to systemic administration of cocaine (10 mg/kg, IP). Intra-NAc shell infusion of 3 μg of fluoxetine or fluvoxamine enhanced cocaine-induced hyperactivity, while infusion of fluoxetine (1 μM) through the microdialysis probe implanted into the NAc shell enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. Thus, the ability of systemic injection of SSRIs to enhance cocaine-evoked hyperactivity and DA efflux in the NAc is mediated in part by local actions of the SSRIs in the NAc.

Original languageEnglish (US)
Pages (from-to)342-353
Number of pages12
JournalNeuropharmacology
Volume44
Issue number3
DOIs
StatePublished - Mar 2003

Fingerprint

Nucleus Accumbens
Serotonin Uptake Inhibitors
Locomotion
Cocaine
Dopamine
Fluoxetine
Fluvoxamine
Serotonin
Microdialysis
Sprague Dawley Rats
Injections

Keywords

  • Cocaine
  • Dopamine microdialysis
  • Fluoxetine
  • Fluvoxamine
  • Locomotor activity
  • Nucleus accumbens

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. / Bubar, M. J.; McMahon, L. R.; De Deurwaerdère, P.; Spampinato, U.; Cunningham, Kathryn.

In: Neuropharmacology, Vol. 44, No. 3, 03.2003, p. 342-353.

Research output: Contribution to journalArticle

Bubar, M. J. ; McMahon, L. R. ; De Deurwaerdère, P. ; Spampinato, U. ; Cunningham, Kathryn. / Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. In: Neuropharmacology. 2003 ; Vol. 44, No. 3. pp. 342-353.
@article{97eb5646177e4060941dc0c663090b09,
title = "Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens",
abstract = "The role for serotonin (5-HT) in mediating the behavioral effects of cocaine may be related in part to the ability of 5-HT to modulate the function of the dopamine (DA) mesoaccumbens pathways. In the present study, the ability of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine (10 mg/kg, IP) and fluvoxamine (10 and 20 mg/kg, IP) to alter cocaine (10 mg/kg, IP)-induced hyperactivity and DA release in the nucleus accumbens (NAc) was analyzed in male Sprague-Dawley rats. Systemic administration of either fluoxetine or fluvoxamine enhanced cocaine-induced locomotor activity in a dose-dependent manner; fluoxetine (10 mg/kg, IP) also enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. To test the hypothesis that the NAc serves as the locus of action underlying these effects following systemic cocaine administration, fluoxetine (1 and 3 μg/0.2 μl/side) or fluvoxamine (1 and 3 μg/0.2 μl/side) was microinfused into the NAc shell prior to systemic administration of cocaine (10 mg/kg, IP). Intra-NAc shell infusion of 3 μg of fluoxetine or fluvoxamine enhanced cocaine-induced hyperactivity, while infusion of fluoxetine (1 μM) through the microdialysis probe implanted into the NAc shell enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. Thus, the ability of systemic injection of SSRIs to enhance cocaine-evoked hyperactivity and DA efflux in the NAc is mediated in part by local actions of the SSRIs in the NAc.",
keywords = "Cocaine, Dopamine microdialysis, Fluoxetine, Fluvoxamine, Locomotor activity, Nucleus accumbens",
author = "Bubar, {M. J.} and McMahon, {L. R.} and {De Deurwaerd{\`e}re}, P. and U. Spampinato and Kathryn Cunningham",
year = "2003",
month = "3",
doi = "10.1016/S0028-3908(02)00381-7",
language = "English (US)",
volume = "44",
pages = "342--353",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens

AU - Bubar, M. J.

AU - McMahon, L. R.

AU - De Deurwaerdère, P.

AU - Spampinato, U.

AU - Cunningham, Kathryn

PY - 2003/3

Y1 - 2003/3

N2 - The role for serotonin (5-HT) in mediating the behavioral effects of cocaine may be related in part to the ability of 5-HT to modulate the function of the dopamine (DA) mesoaccumbens pathways. In the present study, the ability of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine (10 mg/kg, IP) and fluvoxamine (10 and 20 mg/kg, IP) to alter cocaine (10 mg/kg, IP)-induced hyperactivity and DA release in the nucleus accumbens (NAc) was analyzed in male Sprague-Dawley rats. Systemic administration of either fluoxetine or fluvoxamine enhanced cocaine-induced locomotor activity in a dose-dependent manner; fluoxetine (10 mg/kg, IP) also enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. To test the hypothesis that the NAc serves as the locus of action underlying these effects following systemic cocaine administration, fluoxetine (1 and 3 μg/0.2 μl/side) or fluvoxamine (1 and 3 μg/0.2 μl/side) was microinfused into the NAc shell prior to systemic administration of cocaine (10 mg/kg, IP). Intra-NAc shell infusion of 3 μg of fluoxetine or fluvoxamine enhanced cocaine-induced hyperactivity, while infusion of fluoxetine (1 μM) through the microdialysis probe implanted into the NAc shell enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. Thus, the ability of systemic injection of SSRIs to enhance cocaine-evoked hyperactivity and DA efflux in the NAc is mediated in part by local actions of the SSRIs in the NAc.

AB - The role for serotonin (5-HT) in mediating the behavioral effects of cocaine may be related in part to the ability of 5-HT to modulate the function of the dopamine (DA) mesoaccumbens pathways. In the present study, the ability of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine (10 mg/kg, IP) and fluvoxamine (10 and 20 mg/kg, IP) to alter cocaine (10 mg/kg, IP)-induced hyperactivity and DA release in the nucleus accumbens (NAc) was analyzed in male Sprague-Dawley rats. Systemic administration of either fluoxetine or fluvoxamine enhanced cocaine-induced locomotor activity in a dose-dependent manner; fluoxetine (10 mg/kg, IP) also enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. To test the hypothesis that the NAc serves as the locus of action underlying these effects following systemic cocaine administration, fluoxetine (1 and 3 μg/0.2 μl/side) or fluvoxamine (1 and 3 μg/0.2 μl/side) was microinfused into the NAc shell prior to systemic administration of cocaine (10 mg/kg, IP). Intra-NAc shell infusion of 3 μg of fluoxetine or fluvoxamine enhanced cocaine-induced hyperactivity, while infusion of fluoxetine (1 μM) through the microdialysis probe implanted into the NAc shell enhanced cocaine (10 mg/kg, IP)-induced DA efflux in the NAc. Thus, the ability of systemic injection of SSRIs to enhance cocaine-evoked hyperactivity and DA efflux in the NAc is mediated in part by local actions of the SSRIs in the NAc.

KW - Cocaine

KW - Dopamine microdialysis

KW - Fluoxetine

KW - Fluvoxamine

KW - Locomotor activity

KW - Nucleus accumbens

UR - http://www.scopus.com/inward/record.url?scp=0037371559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037371559&partnerID=8YFLogxK

U2 - 10.1016/S0028-3908(02)00381-7

DO - 10.1016/S0028-3908(02)00381-7

M3 - Article

C2 - 12604093

AN - SCOPUS:0037371559

VL - 44

SP - 342

EP - 353

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -